OI
32
-2
SBUX
48
13
PPL
49
2
MCD
52
2
LNC
35
3
MAS
40
4
CI
38
5
COF
42
3
KR
46
-3
JNPR
67
2
TXN
35
7
D
50
2
CTAS
39
3
IVZ
45
2
EXR
30
6
PM
56
6
NVDA
56
5
AMT
32
4
EIX
58
-3
EMC
36
9
OI
32
-2
SBUX
48
13
PPL
49
2
MCD
52
2
LNC
35
3
MAS
40
4
CI
38
5
COF
42
3
KR
46
-3
JNPR
67
2
TXN
35
7
D
50
2
CTAS
39
3
IVZ
45
2
EXR
30
6
PM
56
6
NVDA
56
5
AMT
32
4
EIX
58
-3
EMC
36
9
Financhill
Back

Santen Pharmaceutical Stock Predictions

Today's Fastest Growing Company Might Surprise You

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38

SNPHY
Santen Pharmaceutical

Last Price:
$10.04
Seasonality Move:
-3%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Santen Pharmaceutical Stock Forecast

  • Over the next 52 weeks, Santen Pharmaceutical has on average historically risen by 0.1% based on the past 13 years of stock performance.
  • Santen Pharmaceutical has risen higher in 6 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.15%
  • Is Santen Pharmaceutical Stock Undervalued?
    The current Santen Pharmaceutical [SNPHY] share price is $10.04. The Score for SNPHY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • SNPHY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Santen Pharmaceutical Stock Go Up Next Year?

  • Over the next 52 weeks, Santen Pharmaceutical has on average historically risen by 0.1% based on the past 13 years of stock performance.

Santen Pharmaceutical Stock Rating

Sell
38
Santen Pharmaceutical (SNPHY) is a Sell

Is Santen Pharmaceutical overpriced?

  • Santen Pharmaceutical has risen higher in 6 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.15%

Santen Pharmaceutical Stock Price History

Is SNPHY stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNPHY is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Japan
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
santen.co.jp

52-Week Data

52-Week High:
13.00
52-Week Low:
8.95

Prediction Charts

Market Cap:
3.5B
Price in USD:
10.04
Volume:
2.4K
Beta:
0.39

Technical Analysis

SMA50:
10.90
SMA100:
11.59
SMA200:
10.94
52-Wk Change:
3.43%

Stock Predictions

  • Is Santen Pharmaceutical stock public?
    Yes, Santen Pharmaceutical is a publicly traded company.
  • What is the Santen Pharmaceutical stock quote today?
    The Santen Pharmaceutical stock price is 10.04 USD today.
  • How to buy Santen Pharmaceutical stock online?
    You can buy Santen Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-13 10.76 10.45 10.98 10.01
Dec-16 10.38 10.58 10.75 10.34
Dec-17 10.55 10.24 10.55 10.16
Dec-18 10.49 9.92 10.49 9.92
Dec-19 9.42 9.67 9.80 9.42
Dec-20 9.90 9.88 9.94 9.49
Dec-23 9.84 9.68 9.88 9.48
Dec-24 10.18 10.93 10.93 10.18
Dec-26 9.46 9.93 10.01 9.46
Dec-27 10.30 10.08 10.62 10.08
Dec-30 9.25 9.25 10.22 9.25
Dec-31 9.32 10.12 10.35 9.32
Jan-2 10.11 10.16 10.16 9.85
Jan-3 10.50 10.04 10.50 10.01

Santen Pharmaceutical Earnings

Data Unavailable

Santen Pharmaceutical Forecast Revenue Growth

Data Unavailable

* Santen Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.